SBA-15 ordered mesoporous silica inside a bioactive glass-ceramic scaffold for local drug delivery

被引:31
作者
Cauda, V. [1 ]
Fiorilli, S. [1 ,2 ]
Onida, B. [1 ,3 ]
Verne, E. [1 ]
Brovarone, C. Vitale [1 ]
Viterbo, D. [4 ]
Croce, G. [4 ]
Milanesio, M. [4 ]
Garrone, E. [1 ,3 ]
机构
[1] Politecn Torino, Dipartimento Sci Mat & Ingn Chim, Turin, Italy
[2] Italian Minist Educ Univ & Res, LaTEMAR, Ctr Excellence, Turin, Italy
[3] Politecn Torino, Unita Ric, INSTM, Turin, Italy
[4] Univ Piemonte, Dipartimento Sci & Tecnol Avanzate, Alessandria, Italy
关键词
D O I
10.1007/s10856-008-3468-4
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The paper reports the synthesis of an ordered silica mesostructure of the SBA-15 type inside a macroporous bioactive glass-ceramic scaffold of the type SiO2-CaO-K2O, to combine the bioactivity of the latter with the release properties of the former, in view of local drug delivery from implants designed for tissue engineering. The standard procedure for SBA-15 synthesis has been modified to minimize the damage to the scaffold caused by the acidic synthesis medium. The composite system has been characterized by means of Scanning Electron Microscopy (coupled with EDS analysis), Small Angle X-Ray Diffraction, Thermogravimetry analysis and Infrared Spectroscopy: the formation of a well ordered hexagonal mesostructure was confirmed. Ibuprofen has been chosen as model drug. The uploading properties have been investigated of the scaffold-mesoporous silica composite as compared with the scaffold as such, and a five-fold increase in the adsorbing properties toward ibuprofen was found, due to the presence of the ordered mesoporous silica. The ibuprofen release to a SBF solution in vitro is complete in 1 day. Retention of bioactivity from the glass-ceramic scaffold after the silica mesostructure incorporation has been observed.
引用
收藏
页码:3303 / 3310
页数:8
相关论文
共 43 条
[1]   Silica xerogel carrier material for controlled release of toremifene citrate [J].
Ahola, M ;
Kortesuo, P ;
Kangasniemi, I ;
Kiesvaara, J ;
Yli-Urpo, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) :219-227
[2]   First performance assessment of the small-angle X-ray scattering beamline at ELETTRA [J].
Amenitsch, H ;
Rappolt, M ;
Kriechbaum, M ;
Mio, H ;
Laggner, P ;
Bernstorff, S .
JOURNAL OF SYNCHROTRON RADIATION, 1998, 5 :506-508
[3]   Bioactivity in glass/PMMA composites used as drug delivery system [J].
Arcos, D ;
Ragel, CV ;
Vallet-Regí, M .
BIOMATERIALS, 2001, 22 (07) :701-708
[4]   Mechanism of mesoporous silica formation.: A time-resolved NMR and TEM study of silica-block copolymer aggregation [J].
Flodström, K ;
Wennerström, H ;
Alfredsson, V .
LANGMUIR, 2004, 20 (03) :680-688
[5]   In situ synchrotron small-angle X-ray scattering/X-ray diffraction study of the formation of SBA-15 mesoporous silica [J].
Flodström, K ;
Teixeira, CV ;
Amenitsch, H ;
Alfredsson, V ;
Lindén, M .
LANGMUIR, 2004, 20 (12) :4885-4891
[6]  
Gomez-Vega JM, 2001, J BIOMED MATER RES, V56, P382, DOI 10.1002/1097-4636(20010905)56:3<382::AID-JBM1107>3.0.CO
[7]  
2-P
[8]   A novel route to highly porous bioactive silica gels [J].
Hall, SR ;
Walsh, D ;
Green, D ;
Oreffo, R ;
Mann, S .
JOURNAL OF MATERIALS CHEMISTRY, 2003, 13 (02) :186-190
[9]  
Hammersley A. P., 1995, FIT2D V5 18 REFERENC
[10]   Two-dimensional detector software: From real detector to idealised image or two-theta scan [J].
Hammersley, AP ;
Svensson, SO ;
Hanfland, M ;
Fitch, AN ;
Hausermann, D .
HIGH PRESSURE RESEARCH, 1996, 14 (4-6) :235-248